The impact of glycated hemoglobin A1c on cardiovascular risk in patients with and without coronary artery disease

Back

ESC Professional Premium Access

The impact of glycated hemoglobin A1c on cardiovascular risk in patients with and without coronary artery disease

Session: Diabetes and the heart (3)

Topic: Diabetes and the Heart

Speaker: Doctor K. Olesen (Aarhus, DK)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Kevin Kris Warnakula Olesen

Aarhus University Hospital, Aarhus (Denmark)

2 presentations

0 follower

6 more presentations in this session

Risk of incident renal cell carcinoma in patients with type 2 diabetes on sodium-glucose co-transporter-2 inhibitor users: a population-based cohort study

Speaker: Professor G. Jong (Taichung, TW)

Fifteen-year follow-up and impact of age and sex on cardiovascular outcomes in diabetes and non-diabetes patients without CAD

Speaker: Doctor P. Thrane (Aarhus, DK)

Impact of glycated hemoglobin A1c on cardiovascular risk in diabetes patients with and without coronary artery disease

Speaker: Doctor M. Hansen (Aarhus, DK)

Elevated remnant cholesterol in atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study

Speaker: Doctor B. Nilsson Wadstrom (Copenhagen, DK)

Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on vascular function and liver steatosis in diabetes

Speaker: Doctor I. Ikonomidis (Athens, GR)

Access the full session

Diabetes and the heart (3)

Speakers: Doctor K. Olesen, Professor G. Jong, Doctor P. Thrane, Doctor M. Hansen, Doctor B. Nilsson Wadstrom...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources